After a decades-long global stop of research on psychedelic drugs, investigation of psychedelics in the context of psychiatric disorders is yielding some positive results.
When talking about work issues, Dr Bernstein recommends trying not to focus too much on how awful things are because it can be disheartening.
COVID-19 has caused disruptions all across the world. In this piece, we take a look at what working during the pandemic has been like for psychiatric residents, as well as opportunities that the current situation has offered for learning.
This review examines the nerurobiological mechanisms, risk factors, conceptual models, clinical challenges and management for individuals with antidepressant associated hypomania. Greater clarity is required regarding underlying biological mechanisms and the best treatment approaches to assist with clinical decision-making.
Since publication of the last full practice guideline and guideline watch on schizophrenia, there have been a multitude of studies on new pharmacological and nonpharmacological treatments for schizophrenia.